SP

Sidharth Pant

Active Director Director DIN 03377078
DIN 03377078 First appointment Sep 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sidharth Pant

Data last updated:

Sidharth Pant is a Director at Lucknow Cancer Institute & Hospital Private Limited (since 2024). The company operates in Healthcare.

DIN 03377078
Primary Designation Director
Industry Healthcare
First Appointment 17 Sep 2024
Oldest Company Age 15 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Sep 20242011Active

Directorship timeline

Open interactive timeline →
Lucknow Cancer Institute & Hospital Private Limited
Premium access

Shareholding and investment profile for Sidharth Pant

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sidharth Pant

Sidharth Pant currently holds 1 directorship: Lucknow Cancer Institute & Hospital Private Limited (Director, since 17 Sep 2024).

Sidharth Pant was first appointed on 17 Sep 2024 as Director at Lucknow Cancer Institute & Hospital Private Limited.

The current boards of Sidharth Pant's companies include Animesh Upreti (Lucknow Cancer Institute & Hospital Private Limited), Ganesh Kumar Singh (Lucknow Cancer Institute & Hospital Private Limited), Nirmala Pant (Lucknow Cancer Institute & Hospital Private Limited), Reha Rakholia (Lucknow Cancer Institute & Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available